Tech Company Financing Transactions
Cellular Origins Funding Round
On 12/9/2025, Cellular Origins announced $40 million in Series A financing from Johnson & Johnson Development Corporation, BGF Ventures and Highland Europe.
Transaction Overview
Company Name
Announced On
12/9/2025
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Proceeds Purpose
This investment gives us access to the capital and networks to drive our next phase of growth.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
TTP Campus, Cambridge Road
Melbourn, SG8 6HQ
UK
Melbourn, SG8 6HQ
UK
Phone
Website
Email Address
Overview
Cell therapies have shown the ability to cure the incurable -- the time is ripe for our technologies. We are dedicated to build the future of cell therapy manufacturing. Constellation® will be the world's most scalable, cost-effective, adaptable and space efficient system to manufacture cell and gene therapies. At Cellular Origins, it's our people who drive our mission to transform lives through advanced cell therapy manufacturing.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Edwin Stone
Browse more venture capital transactions:
Prev: 12/9/2025: Noovo venture capital transaction
Next: 12/9/2025: Bags venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs